New Issue: BioMimetic secures $2.92 million from private placement of shares

By Devika Patel

Knoxville, Tenn., June 26 - BioMimetic Therapeutics, Inc. settled a $2.92 million private placement of stock on June 25, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 343,406 common shares at $8.50 per share to Novo A/S.

BioMimetic is a Franklin, Tenn., pharmaceutical company.

Issuer:	BioMimetic Therapeutics, Inc.
Issue:	Common stock
Amount:	$2,918,951
Shares:	343,406
Price:	$8.50
Warrants:	No
Investor:	Novo A/S
Settlement date:	June 25
Stock symbol:	Nasdaq: BMTI
Stock price:	$10.52 at close June 25
Market capitalization:	$207 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.